PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria

Rev Clin Esp (Barc). 2024 May;224(5):272-280. doi: 10.1016/j.rceng.2024.04.010. Epub 2024 Apr 18.

Abstract

Background: Acute hepatic porphyrias (AHPs) are a group of rare diseases that encompasses acute intermittent porphyria, variegate porphyria, hereditary coproporphyria, and 5-aminolaevulinic acid dehydratase deficiency porphyria. Symptoms of AHP are nonspecific which, together with its low prevalence, difficult the diagnosis and follow-up of these patients.

Material and methods: This project used DELPHI methodology to answer PICO questions related to management of patients with AHPs. The objective was to reach a consensus among multidisciplinary porhyria experts providing answers to those PICO questions for improving diagnosis and follow-up of patients with AHP.

Results: Ten PICO questions were defined and grouped in four domains: 1. Biochemical diagnosis of patients with AHP. 2. Molecular tests for patients with AHP. 3. Follow-up of patients with AHP. 4. Screening for long-term complications of patients with AHP.

Conclusions: PICO questions and DELPHI methodology have provided a consensus on relevant and controversial issues for improving the management of patients with AHP.

Keywords: Acute hepatic porphyria; DELPHI methodology; Enfermedades minoritarias; Metodología DELPHI; PICO questions; Porfiria; Porfiria hepática aguda; Porphyria; Preguntas PICO; Rare diseases.

MeSH terms

  • Consensus
  • Delphi Technique*
  • Humans
  • Porphobilinogen Synthase / deficiency*
  • Porphyrias, Hepatic* / diagnosis
  • Porphyrias, Hepatic* / therapy
  • Quality Improvement

Substances

  • Porphobilinogen Synthase

Supplementary concepts

  • Porphyria, Acute Hepatic